Dr. Martin Champagne is currently Assistant Professor of Pediatrics at the University of Montreal in Montreal, Canada, and is Director of the Bone Marrow Transplant Program and Blood Bank in the Division of Pediatric Hematology/Oncology. Dr. Champagne is also on staff as a medical oncologist at Sainte-Justine Hospital in Montreal and conducts research in pediatric cancers, including pediatric leukemias. Dr. Champagne received his medical degree from the University of Sherbrooke and completed his residency in Internal Medicine also at the University of Sherbrooke in Sherbrooke, Quebec, Canada. He completed his fellowship in Hematology at the University of Montreal, his fellowship in Medical Oncology at the University of British Columbia in Vancouver, B.C., and his research fellowship in Pediatric Oncology at Johns Hopkins University.
Cancer Drug Studied in Children with Rare Form of Leukemia
STI-571, also known as Gleevec, was approved for the treatment of chronic myeloid leukemia, or CML, one of the four main types of leukemia. It has also achieved remarkable clinical trial results in... [more]